Hovedundersøgelsen med Inovelon omfattede 139 patienter i alderen 4- 30 år, hvoraf tre fjerdedele var under 17 år.
The main study of Inovelon involved 139 patients aged between 4 and 30 years, of whom three quarters were below 17 years old.